← back to search
Kelledy Manson
BioNTech (United States) · US
Area of research
Immunology · Virology
Research interest
Research interests include HIV Research and Treatment, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, and Herpesvirus Infections and Treatments.
h-index
37
citations
5,778
works
57
NIH funding
—
primary concept
Biology
email
✉ Find email ↗
Recent publications
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer
Cancer Cell
2022
cited by
218
position: middle
doi
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Cell
2020
cited by
734
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Melissa A. Moles
· BioNTech (United States)
1
papers (2022–2022)
John Srouji
· BioNTech (United States)
1
papers (2022–2022)
Victoria Kohler
· BioNTech (United States)
1
papers (2022–2022)
Michael S. Rooney
· BioNTech (United States)
1
papers (2022–2022)
Lakshmi Srinivasan
· Royal Stoke University Hospital
1
papers (2022–2022)
Zakaria Khondker
· Harvard University
1
papers (2022–2022)
David R. Spigel
· Henan Cancer Hospital
1
papers (2022–2022)
Mark DeMario
· BioNTech (United States)
1
papers (2022–2022)
Binisha Karki
· BioNTech (United States)
1
papers (2022–2022)
Asaf Poran
· BioNTech (United States)
1
papers (2022–2022)
Meghan E. Bushway
· BioNTech (United States)
1
papers (2022–2022)
Himanshu Sethi
· Natera (United States)
1
papers (2022–2022)
Edward B. Garon
· Cancer Clinic
1
papers (2022–2022)
Ekaterina Esaulova
· ITMO University
1
papers (2022–2022)
Ramaswamy Govindan
· Huntsman Cancer Institute
1
papers (2022–2022)
Kristen N. Balogh
· BioNTech (United States)
1
papers (2022–2022)
Mark M. Awad
· PCAS (France)
1
papers (2022–2022)
Tracey Sciuto
· BioNTech (United States)
1
papers (2022–2022)
Rohit Vyasamneni
· BioNTech (United States)
1
papers (2022–2022)
Suchitra Ramesh
· BioNTech (United States)
1
papers (2022–2022)